42 related articles for article (PubMed ID: 24765752)
1. Building bridges and providing transparency to the hepatitis C virus drug approval process.
Ghany MG; Liang TJ
Gastroenterology; 2014 Dec; 147(6):1201-3. PubMed ID: 25449025
[No Abstract] [Full Text] [Related]
2. Why Sovaldi shouldn't cost $84,000.
Goozner M
Mod Healthc; 2014 May; 44(18):26. PubMed ID: 25033627
[No Abstract] [Full Text] [Related]
3. Recent advances in the treatment of hepatitis C.
Dhingra A; Kapoor S; Alqahtani SA
Discov Med; 2014 Oct; 18(99):203-8. PubMed ID: 25336034
[TBL] [Abstract][Full Text] [Related]
4. Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir.
Donaldson EF; Harrington PR; O'Rear JJ; Naeger LK
Hepatology; 2015 Jan; 61(1):56-65. PubMed ID: 25123381
[TBL] [Abstract][Full Text] [Related]
5. Payers consider waiting out budget-busting hepatitis C drug.
Carroll J
Manag Care; 2014 May; 23(5):7, 9. PubMed ID: 25016845
[No Abstract] [Full Text] [Related]
6. Antiviral treatment of hepatitis C.
Feeney ER; Chung RT
BMJ; 2014 Jul; 348():g3308. PubMed ID: 25002352
[TBL] [Abstract][Full Text] [Related]
7. Nobel Prize for the Discovery of Hepatitis B and C: A Brief History in Time.
Al-Mahtab M; Roy PP; Khan MSI; Akbar SM
Euroasian J Hepatogastroenterol; 2020; 10(2):98-100. PubMed ID: 33511072
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Chronic Hepatitis C Infection with Sofosbuvir-Based Regimens in a Commercially Insured Patient Population.
Barron J; Xie Y; Wu SJ; White J; Singer J; Tulsi B; Rosenberg A
Am Health Drug Benefits; 2016 Sep; 9(6):327-335. PubMed ID: 27924186
[TBL] [Abstract][Full Text] [Related]
9. Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver Disease.
Ward T; Gordon J; Jones B; Bennett H; Webster S; Kalsekar A; Yuan Y; Brenner M; McEwan P
Clin Drug Investig; 2017 Jan; 37(1):61-70. PubMed ID: 27587071
[TBL] [Abstract][Full Text] [Related]
10. Dare to refuse the exorbitant price of Sovaldi!
Prescrire Int; 2014 Nov; 23(154):278. PubMed ID: 25954802
[No Abstract] [Full Text] [Related]
11. Sofosbuvir (Sovaldi) for chronic hepatitis C.
Med Lett Drugs Ther; 2014 Jan; 56(1434):5-6. PubMed ID: 24457562
[No Abstract] [Full Text] [Related]
12. The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.
Ollendorf DA; Tice JA; Pearson SD
JAMA Intern Med; 2014 Jul; 174(7):1170-1. PubMed ID: 24798321
[No Abstract] [Full Text] [Related]
13. Sovaldi ushers in wave of costly hepatitis C drugs.
Manag Care; 2014 Jan; 23(1):51. PubMed ID: 24765752
[No Abstract] [Full Text] [Related]
14. Sovaldi dilemma likely to get worse.
Carroll J
Manag Care; 2014 Sep; 23(9):9, 12. PubMed ID: 25282860
[No Abstract] [Full Text] [Related]
15. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ].
Einecke D
MMW Fortschr Med; 2014 Feb; 156(3):26-7. PubMed ID: 24938054
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
